Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05222659 · ClinicalTrials.gov registry record
Perioperative Glucose and Insulin Changes in Major Urologic Surgeries
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT05222659 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT05222659 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Urological surgery patients will have their blood glucose measured before, during, and after surgery. Blood glucose will be measured using a continuous glucose monitor (CGM) device. We hypothesize the presence of a hyperglycemic state towards the end of surgery due to increased metabolic demand.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2023-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05222659
The ClinicalTrials.gov registry entry for NCT05222659 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05222659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05222659 about?
NCT05222659 is a clinical study titled "Perioperative Glucose and Insulin Changes in Major Urologic Surgeries". Urological surgery patients will have their blood glucose measured before, during, and after surgery. Blood glucose will be measured using a continuous glucose monitor (CGM) device. We hypothesize the presence of a hyperglycemic state towards the end of surgery due to increased metabolic demand.
What is the current status of trial NCT05222659?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-04-15. Estimated completion is 2023-01-05.
Who is sponsoring clinical trial NCT05222659?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.